治疗方案-话题@MedSci

#治疗方案#

313篇内容 | 3035人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1905199, encodeId=3de61905199f3, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle= JNNP：COVID-19大流行对英国多发性硬化症疾病治疗方案的影响, objectType=article, longId=300584, objectId=fbce30058427, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fbce30058427, replyNumber=0, likeNumber=83, createdTime=2022-08-04, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fbce30058427, moduleTitle= JNNP：COVID-19大流行对英国多发性硬化症疾病治疗方案的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fbce30058427)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905180, encodeId=e60e19051808d, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=ESMO Open：Tomuzotuximab vs 西妥昔单抗用作复发/转移性头颈部鳞癌的一线治疗方案的疗效和安全性, objectType=article, longId=217042, objectId=d10c21e042bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d10c21e042bc, replyNumber=0, likeNumber=73, createdTime=2021-12-13, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d10c21e042bc, moduleTitle=ESMO Open：Tomuzotuximab vs 西妥昔单抗用作复发/转移性头颈部鳞癌的一线治疗方案的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d10c21e042bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905186, encodeId=860d1905186bf, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet Oncol：脂质体伊立替康联合亚叶酸和氟尿嘧啶或可成为晚期胆道癌的二线标准治疗方案！, objectType=article, longId=219153, objectId=574821915388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=574821915388, replyNumber=0, likeNumber=82, createdTime=2022-04-26, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=574821915388, moduleTitle=Lancet Oncol：脂质体伊立替康联合亚叶酸和氟尿嘧啶或可成为晚期胆道癌的二线标准治疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=574821915388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905184, encodeId=c3701905184b8, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=实用！吞咽障碍的康复治疗方案汇总, objectType=article, longId=218609, objectId=5160218609f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5160218609f3, replyNumber=0, likeNumber=129, createdTime=2022-01-16, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5160218609f3, moduleTitle=实用！吞咽障碍的康复治疗方案汇总, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5160218609f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905173, encodeId=aafa19051e3d2, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=乳腺癌N0小肿瘤患者应如何选择治疗方案？, objectType=article, longId=213818, objectId=15c0213818a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15c0213818a5, replyNumber=0, likeNumber=78, createdTime=2021-11-16, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15c0213818a5, moduleTitle=乳腺癌N0小肿瘤患者应如何选择治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15c0213818a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905174, encodeId=62dc19051e4db, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=心律失常如何合理制定更优的治疗方案？, objectType=article, longId=214234, objectId=ef3f2142348f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef3f2142348f, replyNumber=0, likeNumber=82, createdTime=2022-05-01, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef3f2142348f, moduleTitle=心律失常如何合理制定更优的治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef3f2142348f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905172, encodeId=e38319051e260, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=NEJM：多西环素治疗方案用于男男同性恋人群直肠衣原体感染, objectType=article, longId=213583, objectId=d14b213583cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d14b213583cb, replyNumber=0, likeNumber=73, createdTime=2022-03-06, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d14b213583cb, moduleTitle=NEJM：多西环素治疗方案用于男男同性恋人群直肠衣原体感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d14b213583cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905185, encodeId=679c1905185bc, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JNER:基于外骨骼的物理治疗方案对亚急性中风康复期间非卧床患者的疗效：一项随机对照试验, objectType=article, longId=218690, objectId=d9df2186901b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9df2186901b, replyNumber=0, likeNumber=114, createdTime=2022-07-18, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9df2186901b, moduleTitle=JNER:基于外骨骼的物理治疗方案对亚急性中风康复期间非卧床患者的疗效：一项随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d9df2186901b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905188, encodeId=8c1a190518813, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=CDSR：痛风患者痛风石治疗方案的相关研究, objectType=article, longId=219509, objectId=85192195092d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85192195092d, replyNumber=0, likeNumber=114, createdTime=2022-04-16, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85192195092d, moduleTitle=CDSR：痛风患者痛风石治疗方案的相关研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85192195092d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905190, encodeId=33e2190519037, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Front Oncol：贝叶斯网状Meta分析比较ALK阳性NSCLC患者一线治疗方案的疗效和安全性, objectType=article, longId=220334, objectId=0e9e2203349a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e9e2203349a, replyNumber=0, likeNumber=94, createdTime=2022-02-15, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e9e2203349a, moduleTitle=Front Oncol：贝叶斯网状Meta分析比较ALK阳性NSCLC患者一线治疗方案的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e9e2203349a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905175, encodeId=9d0c19051e56f, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=急性溃疡出血患者的更佳治疗方案是什么？, objectType=article, longId=215251, objectId=ae7221525109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae7221525109, replyNumber=0, likeNumber=107, createdTime=2021-12-08, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae7221525109, moduleTitle=急性溃疡出血患者的更佳治疗方案是什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae7221525109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905220, encodeId=4581190522022, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=带状疱疹后神经痛能够彻底治愈吗:带状疱疹后神经痛三阶梯治疗方案, objectType=article, longId=246205, objectId=fed424620554, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fed424620554, replyNumber=0, likeNumber=0, createdTime=2022-01-27, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fed424620554, moduleTitle=带状疱疹后神经痛能够彻底治愈吗:带状疱疹后神经痛三阶梯治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fed424620554)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905177, encodeId=cc2019051e77f, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet Oncol：乐伐替尼+依托泊苷+异环磷酰胺，复发/难治性骨肉瘤的新联合治疗方案？, objectType=article, longId=215975, objectId=0cf32159e5f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cf32159e5f1, replyNumber=0, likeNumber=78, createdTime=2022-07-10, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cf32159e5f1, moduleTitle=Lancet Oncol：乐伐替尼+依托泊苷+异环磷酰胺，复发/难治性骨肉瘤的新联合治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cf32159e5f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905182, encodeId=c0f01905182fc, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet Oncol：卡瑞珠单抗联合阿帕替尼有望成为化疗难治性/复发性妊娠滋养细胞肿瘤的挽救治疗方案！, objectType=article, longId=218250, objectId=f5da2182509d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5da2182509d, replyNumber=0, likeNumber=79, createdTime=2022-02-20, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5da2182509d, moduleTitle=Lancet Oncol：卡瑞珠单抗联合阿帕替尼有望成为化疗难治性/复发性妊娠滋养细胞肿瘤的挽救治疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5da2182509d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905176, encodeId=446219051e6e0, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Ⅳ期肺鳞癌病人治疗方案, objectType=article, longId=215303, objectId=3d5e2153031b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d5e2153031b, replyNumber=0, likeNumber=64, createdTime=2021-12-15, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d5e2153031b, moduleTitle=Ⅳ期肺鳞癌病人治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d5e2153031b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905170, encodeId=d8af19051e036, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Eur Arch Otorhinolaryngol：Ectoin ®鼻炎喷雾剂与赛洛唑啉作为急性鼻炎治疗方案的比较, objectType=article, longId=213081, objectId=146b213081e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=146b213081e4, replyNumber=0, likeNumber=76, createdTime=2022-02-12, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=146b213081e4, moduleTitle=Eur Arch Otorhinolaryngol：Ectoin ®鼻炎喷雾剂与赛洛唑啉作为急性鼻炎治疗方案的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=146b213081e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905159, encodeId=e56a1905159fd, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=NEJM：Nivolumab辅助治疗方案用于晚期食管或胃食管交界癌患者III期临床研究获得成功, objectType=article, longId=209558, objectId=b719209558c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b719209558c2, replyNumber=0, likeNumber=78, createdTime=2021-06-27, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b719209558c2, moduleTitle=NEJM：Nivolumab辅助治疗方案用于晚期食管或胃食管交界癌患者III期临床研究获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b719209558c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905157, encodeId=7cbd190515e03, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=J Thorac Oncol：RovalPituzumab tesiine与拓扑替康用作小细胞肺癌二线治疗方案的疗效对比, objectType=article, longId=207881, objectId=1b2f20e88186, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b2f20e88186, replyNumber=0, likeNumber=68, createdTime=2021-06-20, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b2f20e88186, moduleTitle=J Thorac Oncol：RovalPituzumab tesiine与拓扑替康用作小细胞肺癌二线治疗方案的疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b2f20e88186)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905189, encodeId=f39e19051895a, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=国家卫健委：新冠肺炎康复者恢复期血浆临床治疗方案, objectType=article, longId=219551, objectId=ee7f2195510a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee7f2195510a, replyNumber=0, likeNumber=95, createdTime=2022-10-09, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee7f2195510a, moduleTitle=国家卫健委：新冠肺炎康复者恢复期血浆临床治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee7f2195510a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905149, encodeId=64e7190514912, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Lancet：每8周1次的长效卡博特韦-利匹韦林治疗方案用于HIV感染者的治疗, objectType=article, longId=204396, objectId=a3fe20439667, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3fe20439667, replyNumber=0, likeNumber=90, createdTime=2021-05-22, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3fe20439667, moduleTitle=Lancet：每8周1次的长效卡博特韦-利匹韦林治疗方案用于HIV感染者的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3fe20439667)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗方案

2020-05-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JNNP：COVID-19大流行对英国多发性硬化症疾病治疗方案的影响

2022-08-04

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

ESMO Open：Tomuzotuximab vs 西妥昔单抗用作复发/转移性头颈部鳞癌的一线治疗方案的疗效和安全性

2021-12-13

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet Oncol：脂质体伊立替康联合亚叶酸和氟尿嘧啶或可成为晚期胆道癌的二线标准治疗方案！

2022-04-26

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

实用！吞咽障碍的康复治疗方案汇总

2022-01-16

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

乳腺癌N0小肿瘤患者应如何选择治疗方案？

2021-11-16

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

心律失常如何合理制定更优的治疗方案？

2022-05-01

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

NEJM：多西环素治疗方案用于男男同性恋人群直肠衣原体感染

2022-03-06

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JNER:基于外骨骼的物理治疗方案对亚急性中风康复期间非卧床患者的疗效：一项随机对照试验

2022-07-18

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

CDSR：痛风患者痛风石治疗方案的相关研究

2022-04-16

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Front Oncol：贝叶斯网状Meta分析比较ALK阳性NSCLC患者一线治疗方案的疗效和安全性

2022-02-15

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

急性溃疡出血患者的更佳治疗方案是什么？

2021-12-08

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

带状疱疹后神经痛能够彻底治愈吗:带状疱疹后神经痛三阶梯治疗方案

2022-01-27

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet Oncol：乐伐替尼+依托泊苷+异环磷酰胺，复发/难治性骨肉瘤的新联合治疗方案？

2022-07-10

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet Oncol：卡瑞珠单抗联合阿帕替尼有望成为化疗难治性/复发性妊娠滋养细胞肿瘤的挽救治疗方案！

2022-02-20

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Ⅳ期肺鳞癌病人治疗方案

2021-12-15

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Eur Arch Otorhinolaryngol：Ectoin ®鼻炎喷雾剂与赛洛唑啉作为急性鼻炎治疗方案的比较

2022-02-12

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

NEJM：Nivolumab辅助治疗方案用于晚期食管或胃食管交界癌患者III期临床研究获得成功

2021-06-27

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

J Thorac Oncol：RovalPituzumab tesiine与拓扑替康用作小细胞肺癌二线治疗方案的疗效对比

2021-06-20

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

国家卫健委：新冠肺炎康复者恢复期血浆临床治疗方案

2022-10-09

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Lancet：每8周1次的长效卡博特韦-利匹韦林治疗方案用于HIV感染者的治疗

2021-05-22

科室
- - 订阅+
  - 更多科室
工具
服务